1-hexadecyl-2-acetyl-glycero-3-phosphocholine and sodium pertechnetate tc 99m

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with sodium pertechnetate tc 99m in 1 studies

Compound Research Comparison

Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Studies (sodium pertechnetate tc 99m)	Trials (sodium pertechnetate tc 99m)	Recent Studies (post-2010) (sodium pertechnetate tc 99m)
9,156	187	552	3,251	157	306

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barberà, JA; Chung, KF; Lomeña, F; MacNee, W; Masclans, JR; Pavia, J; Piera, C; Roca, J; Rodriguez-Roisin, R	1

Trials

1 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and sodium pertechnetate tc 99m

Article	Year
Salbutamol reduces pulmonary neutrophil sequestration of platelet-activating factor in humans. American journal of respiratory and critical care medicine, 1996, Volume: 154, Issue:2 Pt 1 Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Cross-Over Studies; Double-Blind Method; Erythrocytes; Female; Humans; Indium Radioisotopes; Lung; Male; Neutropenia; Neutrophils; Platelet Activating Factor; Radionuclide Imaging; Sodium Pertechnetate Tc 99m	1996

Article

Year

Salbutamol reduces pulmonary neutrophil sequestration of platelet-activating factor in humans.

American journal of respiratory and critical care medicine, 1996, Volume: 154, Issue:2 Pt 1

Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Cross-Over Studies; Double-Blind Method; Erythrocytes; Female; Humans; Indium Radioisotopes; Lung; Male; Neutropenia; Neutrophils; Platelet Activating Factor; Radionuclide Imaging; Sodium Pertechnetate Tc 99m

1996